Search research articles
Contact Us
Filters
Showing results (981-990 of 1,161) with videos related to
Page
of 117
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2019
Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma
Jian Zhou, Francisco Sanchez-Vega, Raul Caso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer
U A Matulonis, G M Wulf, W T Barry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
European Urology
|
October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
Eugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T Chang, Alexander Penson, Neil B Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Smita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Science Translational Medicine
|
July 31, 2020
Cellular senescence impairs the reversibility of pulmonary arterial hypertension
Diederik E van der Feen, Guido P L Bossers, Quint A J Hagdorn, et al.
Cancer
|
June 24, 2020
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
Caitlin A McIntyre, Sharon A Lawrence, Allison L Richards, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Sebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Page
of 117
Search research articles
Search
Showing results (981-990 of 1,161) with videos related to
Sort By:
Page
of 117
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2019
Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma
Jian Zhou, Francisco Sanchez-Vega, Raul Caso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer
U A Matulonis, G M Wulf, W T Barry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
European Urology
|
October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
Eugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T Chang, Alexander Penson, Neil B Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways
Smita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Science Translational Medicine
|
July 31, 2020
Cellular senescence impairs the reversibility of pulmonary arterial hypertension
Diederik E van der Feen, Guido P L Bossers, Quint A J Hagdorn, et al.
Cancer
|
June 24, 2020
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
Caitlin A McIntyre, Sharon A Lawrence, Allison L Richards, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Sebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Page
of 117